Developing and validating a mathematical tumor growth model driven by patient-specific simultaneous Positron Emission Tomography
(PET) and Magnetic Resonance Imaging (MRI) data to improve surgery and radiotherapy planning, especially for twotypes of tumors:
gliomas, and hepatocellular carcinoma (HCC). This research is carried out in close collaboration with the Department of nuclear
medicine, Erasme Hospital.